These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26895269)

  • 21. Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes.
    Tsai YW; Wen YW; Huang WF; Kuo KN; Chen PF; Shih HW; Lee YC
    Eur J Health Econ; 2010 Jun; 11(3):279-90. PubMed ID: 19649666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing market competition and vendors' size and scope on AlphaBay.
    Paquet-Clouston M; Décary-Hétu D; Morselli C
    Int J Drug Policy; 2018 Apr; 54():87-98. PubMed ID: 29414490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An empirical analysis of the multimarket contact theory in pharmaceutical markets.
    Coronado J; Jiménez-Martín S; Marín PL
    Eur J Health Econ; 2014 Jul; 15(6):623-43. PubMed ID: 23818281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of multiple-source entry on price competition after patent expiration in the pharmaceutical industry.
    Suh DC; Manning WG; Schondelmeyer S; Hadsall RS
    Health Serv Res; 2000 Jun; 35(2):529-47. PubMed ID: 10857475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10 years after implementation of TRIPS obligations in India.
    Pawar MD
    Pharm Pat Anal; 2015; 4(3):147-59. PubMed ID: 26030078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharma industry in India.
    Sundaram VM
    Drug News Perspect; 2008; 21(1):59-63. PubMed ID: 18301810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does brand differentiate pharmaceuticals?
    Bednarik J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competition.
    Chambers DW
    J Am Coll Dent; 1997; 64(2):41-4. PubMed ID: 9270222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jordanian pharmaceutical companies: are their marketing efforts paying off?
    Al-Shaikh MS; Torres IM; Zuniga MA; Ghunaim A
    Health Mark Q; 2011 Apr; 28(2):174-89. PubMed ID: 21590563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New drugs in India over the past 15 years: analysis of trends.
    Ghosh A; Hazra A; Mandal SC
    Natl Med J India; 2004; 17(1):10-6. PubMed ID: 15115225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality.
    Strumann C; Geissler A; Busse R; Pross C
    Eur J Health Econ; 2022 Sep; 23(7):1229-1242. PubMed ID: 34997865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No significant association between anesthesia group concentration and private insurer payments in the United States.
    Sun EC; Dexter F; Macario A; Miller TR; Baker LC
    Anesthesiology; 2015 Sep; 123(3):507-14. PubMed ID: 26192028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice and competition between adult congenital heart disease centers: evidence of considerable geographical disparities and association with clinical or academic results.
    Diller GP; Kempny A; Piorkowski A; Grübler M; Swan L; Baumgartner H; Dimopoulos K; Gatzoulis MA
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):285-91. PubMed ID: 24619322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Comparison Between Different Hospital Market Definition Approaches: An Empirical Analysis of 11 Representative Diseases in Sichuan Province, China.
    Lu L; Chen T; Lan T; Pan J
    Front Public Health; 2021; 9():721504. PubMed ID: 34485239
    [No Abstract]   [Full Text] [Related]  

  • 37. Are pharmaceutical marketing decisions calibrated to communications effects?
    Cavusgil E; Calantone R
    Health Mark Q; 2011 Oct; 28(4):317-36. PubMed ID: 22054028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Structure of the World Pharmaceutical Market: Prioritizing Iran's Target Export Markets.
    Shabaninejad H; Yusefzadeh H; Mehralian G; Rahimi B
    Iran J Pharm Res; 2019; 18(1):546-555. PubMed ID: 31089388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H; Henderson S; Davies N
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.